Irland - engelsk - HPRA (Health Products Regulatory Authority)

theramex ireland limited - ethinylestradiol; drospirenone - film-coated tablet - 0.02 mg / 3 milligram(s) - progestogens and estrogens, fixed combinations; drospirenone and estrogen

Malta - engelsk - Medicines Authority

mithra pharmaceuticals s.a rue saint-georges 5, 4000, liege, belgium - ethinylestradiol, drospirenone - film-coated tablet - ethinylestradiol 0.03 mg drospirenone 3 mg - sex hormones and modulators of the genital system

Malta - engelsk - Medicines Authority

mithra pharmaceuticals s.a rue saint-georges 5, 4000, liege, belgium - ethinylestradiol, drospirenone - film-coated tablet - ethinylestradiol 0.03 mg drospirenone 3 mg - sex hormones and modulators of the genital system

Malta - engelsk - Medicines Authority

bayer plc - drospirenone; ethinylestradiol - film-coated tablet - drospirenone 3 mg; ethinylestradiol 0.03 mg - sex hormones and modulators of the genital system

Malta - engelsk - Medicines Authority

mithra pharmaceuticals s.a rue saint-georges 5, 4000, liege, belgium - ethinylestradiol, drospirenone - film-coated tablet - ethinylestradiol 0.2 mg drospirenone 3 mg - sex hormones and modulators of the genital system

Malaysia - engelsk - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pahang pharmacy sdn. bhd. - drospirenone; ethinylestradiol -

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

viatris limited - drospirenone 3mg; ethinylestradiol 0.02mg;   - tablet - 3 mg/0.02 mg - active: drospirenone 3mg ethinylestradiol 0.02mg   excipient: crospovidone iron oxide red lactose monohydrate magnesium stearate maize starch povidone lactose monohydrate magnesium stearate polacrilin potassium - indicated for use as an oral contraceptive.

Malta - engelsk - Medicines Authority

bayer plc - drospirenone 3 mg, ethinylestradiol 0.02 mg - film-coated tablet

Israel - engelsk - Ministry of Health

bayer israel ltd - drospirenone; ethinylestradiol - film coated tablets - drospirenone 3 mg; ethinylestradiol 0.02 mg - drospirenone and estrogen - drospirenone and estrogen - - oral contraception. - treatment of moderate acne vulgaris in women who seek oral contraception. - treatment of symptoms of premenstrual dysphoric disorder (pmdd ) in women who have chosen oral contraceptives as their method of birth control. the efficacy of yaz for pmdd was not assessed beyond 3 cycles. yaz has not been evaluated for treatment of pms ( premenstrual syndrome ).

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - ethinylestradiol, quantity: 0.02 mg; drospirenone, quantity: 3 mg - tablet - excipient ingredients: polacrilin potassium; magnesium stearate; lactose monohydrate - drospirenone/ethinyloestradiol-alphapharm 3/20 is indicated for use as: ? an oral contraceptive. ? treatment of moderate acne vulgaris in women who seek oral contraception ? treatment of symptoms of premenstrual dysphoric disorder (pmdd) in women who have chosen oral contraceptives as their method of birth control. the efficacy of drospirenone 3 mg/ethinyloestradiol 20 ?g tablets for pmdd was not assessed beyond 3 cycles. drospirenone 3 mg/ethinyloestradiol 20 ?g tablets has not been evaluated for treatment of pms (premenstrual syndrome) (see clinical trials).